Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Review ArticleReview Article
Open Access

Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia

Suliman A. Alsagaby and Fahad A. Alhumaydhi
Saudi Medical Journal April 2019, 40 (4) 317-327; DOI: https://doi.org/10.15537/smj.2019.4.23598
Suliman A. Alsagaby
From the Department of Medical Laboratories Sciences (Alsagaby), Faculty of Applied Medical Sciences, Majmaah University, Majmaah, and from the Department of Medical Laboratories (Alhumaydhi), College of Applied Medical Sciences, Qassim University, Buraydah, Kingdom of Saudi Arabia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Fahad A. Alhumaydhi
From the Department of Medical Laboratories Sciences (Alsagaby), Faculty of Applied Medical Sciences, Majmaah University, Majmaah, and from the Department of Medical Laboratories (Alhumaydhi), College of Applied Medical Sciences, Qassim University, Buraydah, Kingdom of Saudi Arabia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 40 no. 4 317-327
DOI 
https://doi.org/10.15537/smj.2019.4.23598
PubMed 
30957124

Published By 
Saudi Medical Journal
Online ISSN 
1658-3175
History 
  • Published online April 1, 2019.

Copyright & Usage 
Copyright: © Saudi Medical Journal This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Information

  1. Suliman A. Alsagaby, PhD⇑ and
  2. Fahad A. Alhumaydhi, PhD
  1. From the Department of Medical Laboratories Sciences (Alsagaby), Faculty of Applied Medical Sciences, Majmaah University, Majmaah, and from the Department of Medical Laboratories (Alhumaydhi), College of Applied Medical Sciences, Qassim University, Buraydah, Kingdom of Saudi Arabia
  1. Address correspondence and reprint request to: Dr. Suliman A. Alsagaby, Department of Medical Laboratories Sciences, Faculty of Applied Medical Sciences, Majmaah University, Majmaah, Kingdom of Saudi Arabia. E-mail: s.alsaqaby{at}mu.edu.sa ORCID ID: https://orcid.org/0000-0002-2242-5638
View Full Text

Cited By...

  • 9 Citations
  • 9 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia
    Suliman A. Alsagaby, Danish Iqbal, Iqrar Ahmad, Harun Patel, Shabir Ahmad Mir, Yahya Awaji Madkhali, Atif Abdulwahab A. Oyouni, Yousef M. Hawsawi, Fahad A. Alhumaydhi, Bader Alshehri, Wael Alturaiki, Bader Alanazi, Manzoor Ahmad Mir, Waleed Al Abdulmonem
    Scientific Reports 2022 12 1
  • <p>Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients</p>
    Ehsan Farzadfard, Tahereh Kalantari, Gholamhossein Tamaddon
    Journal of Blood Medicine 2020 Volume 11
  • Quantitative proteomics analysis of differentially expressed proteins in activated B-cell-like diffuse large B-cell lymphoma using quantitative proteomics
    Hai-Xia Gao, Aijiang Nuerlan, Gulinaer Abulajiang, Wen-Li Cui, Jing Xue, Wei Sang, Si-Jing Li, Jing Niu, Zhi-Ping Ma, Wei Zhang, Xin-Xia Li
    Pathology - Research and Practice 2019 215 9
  • Omics-based insights into therapy failure of pediatric B-lineage acute lymphoblastic leukemia
    Suliman A. Alsagaby
    Oncology Reviews 2019 13 2
  • Proteomics and Drug Repurposing in CLL towards Precision Medicine
    Dimitra Mavridou, Konstantina Psatha, Michalis Aivaliotis
    Cancers 2021 13 14
  • Synthesis and Evaluation of Novel Isoindoline-1,3-dione Derivatives as Anticancer Agents
    M. A. A. Radwan, F. M. Alminderej, M. Premanathan, A. S. S. Alwashmi, F. A. Alhumaydhi, W. Alturaiki, S. A. Alsagaby
    Russian Journal of Bioorganic Chemistry 2020 46 6
  • TCL1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods
    Hai-Xia Gao, Si-Jing Li, Jing Niu, Zhi-Ping Ma, Aijiang Nuerlan, Jing Xue, Meng-Bo Wang, Wen-Li Cui, Gulinaer Abulajiang, Wei Sang, Wei Zhang, Xin-Xia Li
    Pathology - Research and Practice 2020 216 2
  • Proteomics-based identification of cancer-associated proteins in chronic lymphocytic leukaemia
    Suliman A. Alsagaby, Ian A. Brewis, Rajendran Vijayakumar, Fahad A. Alhumaydhi, Ameen S. Alwashmi, Naif K. Alharbi, Waleed Al Abdulmonem, Mariappan Premanathan, Guy Pratt, Christopher Fegan, Christopher Pepper, Paul Brennan
    Electronic Journal of Biotechnology 2021 52
  • Computational methods for advanced mass spectrometry – a review
    Stephenie C. Alaribe, Blessing E. Titilayo, Ufonobong N. Ikpatt, Akolade R. Oladipupo, Faizah A. Alabi, Richard I. Ikwugbado
    Physical Sciences Reviews 2025
PreviousNext
Back to top

In this issue

Saudi Medical Journal: 40 (4)
Saudi Medical Journal
Vol. 40, Issue 4
1 Apr 2019
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia
Suliman A. Alsagaby, Fahad A. Alhumaydhi
Saudi Medical Journal Apr 2019, 40 (4) 317-327; DOI: 10.15537/smj.2019.4.23598

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia
Suliman A. Alsagaby, Fahad A. Alhumaydhi
Saudi Medical Journal Apr 2019, 40 (4) 317-327; DOI: 10.15537/smj.2019.4.23598
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Harnessing artificial intelligence for infection control and prevention in hospitals
  • Effects of antidiabetic drugs on the level of serum uric acid in patients who have type 2 diabetes
  • The future of personalized medicine in Saudi Arabia
Show more Review Article

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire